Could a simple vitamin pill supercharge eye injections?
NCT ID NCT07133438
Summary
This study is testing if adding an oral vitamin B12-based drug (mecobalamin) to standard anti-VEGF eye injections works better for treating retinal vein occlusion (RVO), a common cause of vision loss. The goal is to see if the pill can protect nerve cells in the eye while the injections reduce swelling, potentially leading to better long-term vision with fewer injections. 120 patients with RVO will be randomly assigned to receive either the standard injections plus the pill or the injections plus a placebo pill for six months, followed by a year of monitoring.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RETINAL VEIN OCCLUSION (RVO) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
No. 1, Friendship Road, Yuanjiagang, Yuzhong District, Chongqing City
RECRUITINGChongqing, 400016, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.